SEB Asset Management AB »

Royalty Pharma shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $13M 270k 47.97

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
FMR
BlackRock
Baillie Gifford & Co
Adage Capital Partners GP
Swedbank AB
State Street Corporation
Vanguard Group
Capital World Investors
Geode Capital Management
Caledonia
Victory Capital Management
Vanguard Capital Management
Northern Trust

View all funds holding Royalty Pharma